Showing 1031-1040 of 1197 results for "".
- Cynosure to Be Acquired by Hologichttps://modernaesthetics.com/news/cynosure-to-be-acquired-by-hologic/2472278/Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Merz On The Move: Reflections On Fiscal Year 2015/16https://modernaesthetics.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2472311/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- AAD Selects ContextMedia:Health as Patient Education Affinity Partnerhttps://modernaesthetics.com/news/aad-selects-contextmediahealth-as-patient-education-affinity-partner/2472318/ContextMedia:Health is now an Affinity Partner with the American Academy of Dermatology (AAD). The partnership offers ContextMedia:Health's suite of digital technology to the AAD's U.S. members at no cost. The agreement also bring
- SkinSpirit Makes Donation to Kerr County Flood Relief Fundhttps://modernaesthetics.com/news/skinspirit-makes-donation-to-kerr-county-flood-relief-fund/2475718/SkinSpirit has donated to the Kerr County Flood Relief Fund as part of their philanthropic arm, SS Gives. “With our large number of Texas-based clinics, we are proud to donate to the Kerr County
- Study: Rohrer Aesthetics Positions PIX:E as Breakthrough in Preventative Aesthetic Medicinehttps://modernaesthetics.com/news/study-rohrer-aesthetics-positions-pixe-as-breakthrough-in-preventative-aesthetic-medicine/2475544/Rohrer Aesthetics has released new clinical findings on its latest treatment platform, PIX:E, in a study recently featured by NewBeauty. The results suggest that PIX:E may offer a new paradigm in aesthetic care—shifting the focus from reactive treatment to preventative skin health. <
- Hydrafacial’s New HydraFillic with Pep9 Booster Targets Fine Line, Wrinkleshttps://modernaesthetics.com/news/hydrafacials-new-hydrafillic-with-pep9-booster-targets-fine-line-wrinkles/2475381/The Hydrafacial Company this week announced its latest innovation, the Hydrafacial HydraFillic with Pep9TM Booster. The HydraFillic with Pep9TM Booster is Hydrafacial’s first peptide-powered booster, formulated with a new proprietary complex of 9 peptides. It
- 2025 SCALE: Enhancing Injection Safety and Precision with Ultrasound Guidancehttps://modernaesthetics.com/news/2025-scale-enhancing-injection-safety-and-precision-with-ultrasound-guidance/2475379/At the 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE), Benjamin Ascher, MD, gave a lecture titled “Why Injections Under Ultrasound Guide Are Crucial in Aesthetic Medicine.” Dr. Ascher explained shifts in facial injection practices,
- Dr. Sebastian Cotofana Shares Unpublished Research Targeting Glabellar Lines with Neurotoxins at SCALEhttps://modernaesthetics.com/news/dr-sebastian-cotofana-shares-unpublished-research-targeting-glabellar-lines-with-neurotoxins-at-scale/2475377/The 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE) was held from May 14 to 18 at the Grand Hyatt in Nashville, Tennessee. The agenda included an update on neurotoxin related to facial anatomy for improved aesthetic outcomes from Seb
- 2025 SCALE: Temple Filler Is Underappreciated But Crucialhttps://modernaesthetics.com/news/2025-scale-temple-filler-is-underappreciated-but-crucial/2475375/At the 20th anniversary of the Music City Symposium for Cosmetic Advances and Laser Education (SCALE), Vince Bertucci, MD, FRCPC, gave a lecture titled “Temple Fillers: Revisiting Current Dogma.” Key takeaway messages from the lecture included: <